Skip to main content
Premium Trial:

Request an Annual Quote

ORIEN Cancer Data Network Adds Rutgers, USC, Morehouse as Collaborators

NEW YORK (GenomeWeb) – The Oncology Research Information Exchange Network (ORIEN) yesterday announced it has added Rutgers Cancer Institute of New Jersey, the University of Southern California Norris Comprehensive Cancer Center, and the Morehouse School of Medicine as members.

"Becoming part of ORIEN adds great opportunities for Rutgers Cancer Institute of New Jersey, enabling discovery based on large-scale, diverse population data as well as patient-specific clinical decision support across a broad, national clinical trial portfolio," Robert DiPaola, director of the Rutgers Cancer Institute of New Jersey, said in a statement.

ORIEN was launched in May 2014 by the Moffitt Cancer Center and Ohio State University Comprehensive Cancer Center to bring together data to drive research collaborations in oncology and personalized medicine. With the new additions, the network now has nine members.

In February, City of Hope, University of Virginia Cancer Center, University of Colorado Cancer Center, and University of New Mexico Cancer Center joined ORIEN.


The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.